Time-dependent impact of diabetes on the mortality of patients on renal replacement therapy: A population-based study in Germany (2002-2009)

Diabetes Research and Clinical Practice

Volumn 92, Issue 3, 2011, Pages 380-385

  Icks, Andrea ^a   Haastert, Burkhard ^b   Genz, Jutta ^a   Giani, Guido ^a   Hoffmann, Falk ^c   Trapp, Rudolf ^d   Koch, Michael ^a,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Leibniz Center for Diabetes Research ^*  (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

^d Center of Nephrology   (Germany)

Author keywords

Diabetes; Mortality; Population based study; Renal replacement therapy

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETER; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSIS; FEMALE; GERMANY; HAZARD RATIO; HEALTH SERVICE; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 79957998640     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.02.021     Document Type: Article

References (29)

1. Bash L.D., Astor B.C., Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the ARIC study. Am J Kidney Dis 2010, 55:31-41.
2. Boddana P., Caskey F., Casula A., Ansell D. UK renal registry 11th annual report (December 2008): chapter 14 UK renal registry and international comparisons. Nephron Clin Pract 2009, 111:c269-c276.
3. Burrows N.R., Li Y., Geiss L.S. Incidence of treatment for end-stage renal disease among individuals with diabetes in the US continues to decline. Diabetes Care 2010, 33:73-77.
4. Hamer R.A., Meguid Ek Nahas A. The burden of chronic kidney disease. BMJ 2006, 332:563-564.
5. Hsu C.Y., Iribarren C., McCulloch C.E., Darbinian J., Go A.S. Risk factors for end-stage renal disease: 25 year follow-up. Arch Intern Med 2009, 169:342-350.
6. Köster I., von Ferber L., Ihle P., Schubert I., Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 2006, 49(7):1498-1504.
7. Roblin D.W., Khoury A., Pisanelli W., Dahar W., Roth M. Risk for incident renal dialysis in a managed care population. Am J Kidney Dis 2006, 48:205-211.
8. Ritz E., Stefanski A. Diabetic nephropathy in type 2 diabetes. Am J Kidney Dis 1996, 27:167-194.
9. Schieppati A., Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 2005, 68(Suppl.):S7-S10.
10. Van Dijk P.C.W., Jager K.J., Stengel B., Grönhagen-Riska C., Feest T.G., Briggs J.D. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005, 67:1489-1499.
11. Schiel R., Heinrich S., Steiner T., Ott U., Stein G. Long-term prognosis of patients after kidney transplantation: a comparison of those with and without diabetes mellitus. Nephrol Dial Transplant 2005, 20:611-617.
12. Sorensen V.R., Mathiesen E.R., Heaf J., Feldt-Rasmussen B. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia 2007, 50:922-929.
13. Khan I.H. Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transplant 1998, 13(Suppl. 1):s76-s79.
14. US Renal Data System (USRDS) Annual data report 2006, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
15. Van Manen J.G., van Dijk P.C.W., Stel V.S., Dekker F.W., Cleries M., Conte F., et al. Confounding effects of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007, 22:187-195.
16. Villar E., Chang S.H., McDonald S.P. Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1991-2005). Diabetes Care 2007, 30:3070-3076.
17. Villar E., Remontet L., Labeeuw M., Ecochard R. Effects of age, sex, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007, 18:2125-2134.
18. Koch M., Thomas B., Tschöpe W., Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993, 36:1113-1117.
19. Koch M., Hollenbeck M., Trapp R., Kulas W., Grabensee B. Value of diabetes as an independent predictor of death in subjects with end-stage renal disease. Med Klin 2006, 101(12):933-937.
20. Lok C.E., Oliver M.J., Rothwell D.M., Hux J.E. The growing volume of diabetes-related dialysis: a population based study. Nephrol Dial Transplant 2004, 19:3098-3103.
21. Karame A., Labeeuw M., Trolliet P., Cailette-Beaudoin A., Cahen R., Ecochard R., et al. The impact of type 2 diabetes on mortality in end-stage renal disease differs between genders. Nephron Clin Pract 2009, 112:c268-c275.
22. Icks A., Haastert B., Gandjour A., Chernyak N., Rathmann W., Giani W., et al. Costs of dialysis-a regional population-based analysis. Nephrol Dial Transplant 2010, 25(5):1647-1652.
23. WHO/IDF (World Health Organization/International Diabetes Federation). Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland: World Health Organization; 2006.
24. Frei U, Schober-Halstenberg HJ. Nierenersatztherapie in Deutschland. Bericht 2005/2006. QuaSi Niere, 2006.
25. United States Renal Data System. (downloaded: March 23, 2010). http://www.usrds.org/qtr/qrt_report_table_c_Q1_09.html.
26. Kleinbaum D.G., Klein M. Survival analysis: a self-learning text 2005, Springer, New York. 2nd ed.
27. Moist L.M., Trpeski L., Na Y., Lok C.E. Increased hemodialysis catheter use in canada and associated mortality risk: data from the canadian organ replacement registry 2001-2004. Clin J Am Soc Nephrol 2008, 3(6):1726-1732.
28. Rao C, Adair T, Bain C, Doi SAR. Mortality from diabetic renal disease: a hidden epidemic. Eur J Public Health. 2011 January 18 (Epub ahead of print).
29. Yokoyama H., Kanno S., Takahashi S., Yamada D., Itoh H., Saito K., et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol 2009, 4:1432-1440.